Genome Designs

Genome Designs said this week that it has formed a partnership with SciDM Group, a bioinformatics tools developer.

NEW YORK (GenomeWeb News) – Life Technologies this week said that it will invest $20 million in expanding its cell culture facility in Inchinnan, Scotland.

Researchers formerly with Argonne National Lab, the National Center for Biotechnology Information, Integrated Genomics, and Ariadne have founded a new startup that will focus on functional annotation of next-generation sequencing projects.

Life Technologies has appointed Ronnie Andrews as president of medical sciences. Previously, he served as CEO of Clarient, where he helped integrate the company when it was acquired by GE Healthcare.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.